Immediate Impact

1 by Nobel laureates 50 standout
Sub-graph 1 of 25

Citing Papers

Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial
2025 Standout
Combating Antibiotic-Resistant Bacterial Infection Using Coassembled Dimeric Antimicrobial Peptide-Based Nanofibers
2025 Standout
2 intermediate papers

Works of Michelle Prickett being referenced

Telehealth and CFTR modulators: Accelerating innovative models of cystic fibrosis care
2022
Polymyxin B Pharmacokinetics in Adult Cystic Fibrosis Patients
2018

Author Peers

Author Last Decade Papers Cites
Michelle Prickett 75 12 37 91 66 16 185
Amir Akhavan Rezayat 137 2 43 55 92 14 282
Giovanna Pizzamiglio 125 56 42 81 16 255
Ana Fernández-González 21 1 19 88 92 17 190
Iman Sami 141 5 135 23 75 21 257
Fei Wang 27 46 34 152 17 282
Francesca Saluzzo 60 64 43 69 18 213
Fadi Asfour 133 26 41 88 17 257
Karianne Wiger Gammelsrud 34 2 41 30 24 15 131
Xinqian Ma 13 39 45 46 19 135
Sophie Ramel 208 1 79 36 44 23 288

All Works

Loading papers...

Rankless by CCL
2026